O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+33.33%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$6.38B
AUM Growth
+$6.38B
(+19%)
Cap. Flow
-$261M
Cap. Flow
% of AUM
-4.1%
Top 10 Holdings %
Top 10 Hldgs %
40.48%
Holding
147
New
18
Increased
25
Reduced
26
Closed
25
Top Buys
| 1 |
Alector
ALEC
|
$247M |
| 2 |
Neurocrine Biosciences
NBIX
|
$118M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$64M |
| 4 |
AVDR
Avedro, Inc Common Stock
AVDR
|
$52M |
| 5 |
ENDP
Endo International plc
ENDP
|
$49.5M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$279M |
| 2 |
Biogen
BIIB
|
$177M |
| 3 |
AGN
Allergan plc
AGN
|
$128M |
| 4 |
CVS Health
CVS
|
$52M |
| 5 |
Centene
CNC
|
$48.1M |
Sector Composition
| 1 | Healthcare | 96.73% |
| 2 | Financials | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$11.8B
| $467M | 7.23% | 3,970,673 -116,700 | -3% | -$13.7M |
|
|
TCDA
2
DELISTED
Tricida, Inc. Common Stock
TCDA
| $421M | 6.51% | 10,889,280 | – | – |
|
|
CMTA
3
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $272M | 4.21% | 10,425,225 | – | – |
|
|
ALXN
4
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $265M | 4.1% | 1,957,200 -90,200 | -4% | -$12.2M |
|
|
5
Alector
ALEC
$238M
| $247M | 3.82% | +13,182,329 | New | +$247M |
|
6
Boston Scientific
BSX
$156B
| $222M | 3.44% | 5,790,400 | – | – |
|
7
Merck
MRK
$210B
| $214M | 3.31% | 2,570,100 +75,100 | +3% | +$6.25M |
|
8
Vertex Pharmaceuticals
VRTX
$100B
| $176M | 2.72% | 955,300 -177,900 | -16% | -$32.7M |
|
|
9
Neurocrine Biosciences
NBIX
$13.8B
| $162M | 2.5% | 1,833,200 +1,339,000 | +271% | +$118M |
|
10
Viatris
VTRS
$12.3B
| $138M | 2.13% | 4,861,800 +875,600 | +22% | +$24.8M |
|
11
Edwards Lifesciences
EW
$47.8B
| $137M | 2.12% | 715,000 +249,400 | +54% | +$47.7M |
|
|
WMGI
12
DELISTED
Wright Medical Group Inc
WMGI
| $132M | 2.04% | 4,187,799 -718,100 | -15% | -$22.6M |
|
13
Thermo Fisher Scientific
TMO
$186B
| $122M | 1.9% | 447,300 +9,800 | +2% | +$2.68M |
|
14
Intuitive Surgical
ISRG
$170B
| $120M | 1.86% | 210,300 +39,800 | +23% | +$22.7M |
|
15
Guardant Health
GH
$8.41B
| $118M | 1.82% | 1,534,464 | – | – |
|
|
THOR
16
DELISTED
Synthorx, Inc. Common Stock
THOR
| $108M | 1.68% | 5,316,355 | – | – |
|
17
Sarepta Therapeutics
SRPT
$1.78B
| $98.7M | 1.53% | 828,400 +47,400 | +6% | +$5.65M |
|
18
Elevance Health
ELV
$71.8B
| $93.3M | 1.44% | 325,200 +19,800 | +6% | +$5.68M |
|
19
Bausch Health
BHC
$2.74B
| $92.4M | 1.43% | 3,740,700 +140,400 | +4% | +$3.47M |
|
|
PRNB
20
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $88.6M | 1.37% | 2,605,713 | – | – |
|
21
Regeneron Pharmaceuticals
REGN
$61.5B
| $88.2M | 1.37% | 214,800 -7,300 | -3% | -$3M |
|
|
DCPH
22
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $84M | 1.3% | 3,618,171 +1,175,971 | +48% | +$27.3M |
|
23
Inspire Medical Systems
INSP
$2.77B
| $83.5M | 1.29% | 1,471,000 -358,449 | -20% | -$20.4M |
|
|
IMMU
24
DELISTED
Immunomedics Inc
IMMU
| $82M | 1.27% | 4,270,403 -697,000 | -14% | -$13.4M |
|
25
eHealth
EHTH
$118M
| $73.6M | 1.14% | 1,181,214 +81,214 | +7% | +$5.06M |
|